BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6495256)

  • 1. Inhibition by heparin of platelet accumulation in vivo.
    Barrett PA; Butler KD; Morley J; Page CP; Paul W; White AM
    Thromb Haemost; 1984 Jul; 51(3):366-70. PubMed ID: 6495256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo model for studying platelet aggregation and disaggregation.
    Page CP; Paul W; Morley J
    Thromb Haemost; 1982 Jun; 47(3):210-3. PubMed ID: 7051409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs].
    Mischke R; Nimmerfall K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of modulation of prostanoid metabolism on the thoracic platelet accumulation induced by intravenous administration of collagen in the guinea-pig.
    Butler KD; Shand RA; Wallis RB
    Thromb Haemost; 1986 Dec; 56(3):263-7. PubMed ID: 3105104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF; May JA; Heptinstall S
    Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective assessment of the interaction of heparin and its fractions with human platelets.
    Brace LD; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):190-8. PubMed ID: 4035366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood platelet function after chronic treatment of rats and guinea pigs with nicotine.
    Becker BF; Terres W; Kratzer M; Gerlach E
    Klin Wochenschr; 1988; 66 Suppl 11():28-36. PubMed ID: 3184777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin on the aggregation function of thrombocytes].
    Zhukovskaia ES; Blindar' VN
    Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of a low molecular weight heparin fragment on platelet aggregation and platelet dependent hemostasis in dogs.
    Ljungberg B; Johnsson H
    Thromb Haemost; 1988 Oct; 60(2):232-5. PubMed ID: 2851192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pulmonary accumulation of 51chromium-labelled rat platelets following intravenous application of ADP and collagen.
    Klee A; Seiffge D
    Thromb Haemost; 1991 May; 65(5):588-95. PubMed ID: 1871721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of local anaesthetics with blood platelet aggregation.
    Jancinová V; Nosál' R; Benes L
    Drugs Exp Clin Res; 1986; 12(9-10):857-60. PubMed ID: 3792211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.